|
CALM1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.7874590696465E-12 |
| Normal-vs-Stage2 |
3.06549999995465E-06 |
| Normal-vs-Stage3 |
8.31149999935832E-08 |
| Normal-vs-Stage4 |
9.83990000591461E-10 |
| Stage1-vs-Stage2 |
6.001600E-01 |
| Stage1-vs-Stage3 |
7.411000E-01 |
| Stage1-vs-Stage4 |
2.262300E-02 |
| Stage2-vs-Stage3 |
8.572600E-01 |
| Stage2-vs-Stage4 |
3.243400E-01 |
| Stage3-vs-Stage4 |
1.283210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62470037423645E-12 |
| Normal-vs-AfricanAmerican |
2.73550071483442E-11 |
| Normal-vs-Asian |
2.181100E-03 |
| Caucasian-vs-AfricanAmerican |
7.983200E-01 |
| Caucasian-vs-Asian |
9.078400E-01 |
| AfricanAmerican-vs-Asian |
9.789400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
3.46110029525448E-10 |
| Male-vs-Female |
6.221000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.2222999995769E-08 |
| Normal-vs-Extreme_Weight |
3.85830034588253E-10 |
| Normal-vs-Obese |
1.667699978114E-09 |
| Normal-vs-Extreme_Obese |
1.99110999999919E-05 |
| Normal_Weight-vs-Extreme_Weight |
7.483800E-01 |
| Normal_Weight-vs-Obese |
5.461800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.791200E-01 |
| Extreme_Weight-vs-Obese |
2.118000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.550000E-01 |
| Obese-vs-Extreme_Obese |
4.755400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.70709999999241E-05 |
| Normal-vs-Age(41-60Yrs) |
3.52773366074643E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
6.32859999999402E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.271600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.544800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.058200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.148200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.347200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.237800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.63125069008174E-12 |
| Normal-VS-Type2 PRCC |
2.90767410149328E-12 |
| Normal-VS-KIRP CIMP |
2.96320001869077E-09 |
| Normal-VS-Unclassified PRCC |
1.06659999721259E-08 |
| Type1 PRCC-VS-Type2 PRCC |
9.339900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.602200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.773200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.839600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.700200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.372790E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.95270532655468E-11 |
| Normal-vs-N1 |
1.19899999928563E-08 |
| Normal-vs-N2 |
6.24169999999813E-05 |
| N0-vs-N1 |
8.345000E-01 |
| N0-vs-N2 |
1.959050E-01 |
| N1-vs-N2 |
8.235800E-02 |
|
|
